Caldwell Sutter Capital’s Gilead Sciences GILD Stock Holding History

Caldwell Sutter Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Sell	7,590 -504	-6%	-$70.6K	0.43%	62
2025 Q4	$993K	Sell	8,094 -214	-3%	-$26K	0.42%	63
2025 Q3	$922K	Sell	8,308 -478	-5%	-$54.3K	0.39%	66
2025 Q2	$974K	Sell	8,786 -224	-2%	-$23.8K	0.45%	59
2025 Q1	$1.01M	Sell	9,010 -697	-7%	-$71.9K	0.48%	55
2024 Q4	$897K	Sell	9,707 -81	-0.8%	-$7.29K	0.42%	64
2024 Q3	$821K	Sell	9,788 -452	-4%	-$34.5K	0.38%	69
2024 Q2	$703K	Buy	10,240 +503	+5%	+$33.6K	0.35%	81
2024 Q1	$713K	Sell	9,737 -51	-0.5%	-$3.92K	0.34%	82
2023 Q4	$793K	Sell	9,788 -146	-1%	-$11.4K	0.4%	67
2023 Q3	$744K	Sell	9,934 -167	-2%	-$12.8K	0.41%	69
2023 Q2	$779K	Buy	10,101 +5,476	+118%	+$437K	0.41%	72
2023 Q1	$384K	Buy	4,625 +4,155	+884%	+$344K	0.28%	84
2022 Q4	$40.4K	Buy	+470	New	+$37.2K	0.04%	189

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Caldwell Sutter Capital's GILD Position: Q1 2026 in Review

Caldwell Sutter Capital reduced its Gilead Sciences (GILD) stake by 6.2% in Q1 2026, selling an estimated $70.6K and leaving 7,590 shares worth $1.06M. The position accounts for 0.43% of the portfolio, ranked #62.

Caldwell Sutter Capital first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Caldwell Sutter Capital held 7,590 shares of Gilead Sciences worth $1.06M as of Q1 2026.
Caldwell Sutter Capital sold 504 Gilead Sciences shares in Q1 2026, an estimated $70.6K.
Gilead Sciences made up 0.43% of Caldwell Sutter Capital's portfolio in Q1 2026, its #62 holding.
Caldwell Sutter Capital first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.